Drug Shortage Report for REMERON RD
Report ID | 164623 |
Drug Identification Number | 02248544 |
Brand name | REMERON RD |
Common or Proper name | (mirtazapine) Orally Disintegrating Tablets |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | MIRTAZAPINE |
Strength(s) | 45MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-07-14 |
Actual start date | 2022-07-14 |
Estimated end date | 2022-11-04 |
Actual end date | 2022-11-03 |
Shortage status | Resolved |
Updated date | 2022-11-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-11-04 | English | Compare |
v8 | 2022-11-03 | French | Compare |
v7 | 2022-11-03 | English | Compare |
v6 | 2022-10-31 | English | Compare |
v5 | 2022-10-21 | English | Compare |
v4 | 2022-09-02 | English | Compare |
v3 | 2022-07-15 | English | Compare |
v2 | 2022-07-14 | French | Compare |
v1 | 2022-07-14 | English | Compare |
Showing 1 to 9 of 9